Analysis of three hundred fifteen ectopic pregnancies treated with single-dose methotrexate.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 9662322.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The objective of this study was to review the largest single series of ectopic pregnancies treated with single-dose methotrexate reported to date. A review of 315 patients with unruptured ectopic pregnancies treated with single-dose methotrexate 50 mg/m2 from March 21, 1990, to March 1, 1997, was performed. Overall 287 patients were successfully treated with methotrexate for a success rate of 90.1%. Six patients electively withdrew and requested surgery within 1 week of starting therapy. Excluding withdrawals the overall success rate was 92.9%. Ten patients with an ectopic pregnancy > 3.5 cm but < or = 4 cm in size were treated for a 90% success rate. Forty-four patients with positive ectopic cardiac activity were treated with an 87.5% success rate. This large series indicates that single-dose intramuscular methotrexate for treatment of ectopic pregnancy is associated with an excellent overall success rate.
Medical subject headings
- Methotrexate
- Nucleic Acid Synthesis Inhibitors
- Pregnancy, Ectopic